Ignite Creation Date:
2025-12-24 @ 10:56 PM
Ignite Modification Date:
2025-12-28 @ 7:53 PM
Study NCT ID:
NCT00706069
Status:
COMPLETED
Last Update Posted:
2009-12-15
First Post:
2008-06-25
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Vinorelbine Oral Plus Capecitabine Combination In Metastatic Breast Cancer
Sponsor:
Hellenic Oncology Research Group
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CT/07.06
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Nikos Malamos
Old Organization:
Hellenic Oncology Research Group
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |